![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
When drugs fail, sometimes it’s not because they don’t work — it’s because they were tested on the wrong population. Auransa’s hypothesis-free machine learning algorithms sort through RNA transcriptome data to find patients with molecular subtypes of diseases that might respond better to known drug compounds. It offers its technology to partners and is developing its own pipeline of novel drugs for liver cancer and other conditions.
Using AI to speed through the last mile of drug discovery
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing